MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]

Ariadne Bio has launched with funding from The Michael J [...]

Skyhawk Therapeutics’ investigational oral treatment SKY-0515 showed a 1.59-point difference [...]

A US National Institutes of Health grant will fund an [...]

Amyl Therapeutics has raised €8.25m to generate preclinical data for [...]

A $3m research programme will fund four projects investigating the [...]

Limbic has been selected for the US Food and Drug [...]

Researchers at Dongguk University in South Korea have developed an [...]